financing
Hememics Biotechnologies Closes $2M Seed 2 Round
The firm is developing a handheld multiplexed biosensor platform to detect antibodies, antigens, and molecular targets simultaneously.
Foresight Diagnostics Closes $58.8M Series B Round
The Aurora, Colorado-based company plans to accelerate the clinical development and commercialization of its PhasED-seq MRD testing platform.
Epic Sciences Raises $24M, Expands Commercial Infrastructure for Breast Cancer Liquid Biopsy Test
The firm is growing its sales, product marketing, and customer service teams for its multiomic metastatic breast cancer liquid biopsy test, DefineMBC.
Mercy BioAnalytics Raises $41M in Series A Financing
The proceeds will help develop and commercialize its extracellular vesicle-based Mercy Halo platform for lung, ovarian, and other cancer screening tests.
Previse Launches Esophageal Cancer Risk Test, Raises $3M to Support Commercial Expansion
The company hopes to build prospective clinical utility evidence for the Esopredict test, its first clinical assay, to support future reimbursement.
Mar 21, 2023
Vitestro Raises €12 million in Series A Round
Feb 6, 2023
Simple HealthKit Raises $8M in Series A Round
Dec 21, 2022
Dec 12, 2022
Senzo Secures $1.9M Equity Funding
Nov 16, 2022
Novigenix Raises $14M in First Closing of Series B
Sep 8, 2022
Morgan Health Invests $20M in LetsGetChecked
Aug 19, 2022
Accelerate Prices $35M Public Stock Offering
Jul 18, 2022
Delfi Diagnostics Raises $225M in Series B Financing
Jul 1, 2022